Subclinical hypothyroidism: new trials, old caveats

Area of Science:

• Endocrinology
• Internal Medicine

Background:

• Subclinical hypothyroidism (SH) diagnosis and levothyroxine treatment indications are debated, particularly in elderly patients.
• The TRUST trial found no symptom improvement with levothyroxine in elderly SH patients.
• Differential diagnosis of elevated TSH is often overlooked.

Purpose of the Study:

• To review the diagnostic considerations for subclinical hypothyroidism (SH) before initiating levothyroxine therapy.
• To highlight the importance of differential diagnosis for elevated TSH levels.
• To guide endocrinologists and internists in managing SH.

Main Methods:

• Review of clinical guidelines and trial data.
• Discussion of diagnostic steps for elevated TSH.
• Analysis of factors influencing levothyroxine treatment decisions in SH.

Main Results:

• Levothyroxine did not improve clinical symptom scores in elderly SH patients (TRUST trial).
• Exclusion of isolated TSH elevation and verification of persistent SH are critical.
• Documentation of SH symptoms and patient-specific complications is necessary.

Conclusions:

• Before initiating levothyroxine for SH, clinicians must exclude other causes of elevated TSH, confirm persistence, document symptoms, and clarify patient expectations.
• A thorough diagnostic workup is essential for appropriate SH management.
• The decision to treat SH with levothyroxine requires careful individual assessment.